Phase
Condition
Tendon Injuries
Sprains
Treatment
Adrenaline 1 Mg/mL Solution for Injection
Adrenaline 0,33 Mg/mL Solution for Injection
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient over 18 years of age, having read and signed the consent form forparticipation in the study after a reflection period (approximately 15 minutes)
Patient with a rotator cuff pathology (subacromial impingement, long bicepstendinopathy or rotator cuff tendinopathy)
Patient for whom an arthroscopic surgical indication has been given
Exclusion
Exclusion Criteria:
Allergy to epinephrine
History of Takotsubo cardiomyopathy
Coagulation disorder
Patient under court protection, guardianship or curatorship
Patient not affiliated to the French social security system
Patient participating in another therapeutic protocol
Breastfeeding woman,
Pregnant woman or woman of childbearing age without highly effective contraceptionfor the duration of the study (surgically sterile, intrauterine device (> 14 days),hormonal contraception (same dose and formulation for at least 6 months), sexualabstinence. Women of childbearing age, i.e. fertile, are considered to bepost-menopausal unless they are permanently infertile or have undergone surgicalsterilisation. A post-menopausal condition is defined as the absence of menstruationfor 12 months without any other medical cause
Patient unable to understand informed information and/or give written informedconsent: dementia, psychosis, disturbed consciousness, non-French speaking patient
Study Design
Study Description
Connect with a study center
Clinique de l'Atlantique
Puilboreau, 17138
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.